The weekly litigation news digest is live. Subscribe now

IP Verse

A Cell Mediated Immune Response Assay With Enhanced Sensitivity - EP3351936

The patent EP3351936 was granted to Cellestis on Jan 8, 2025. The application was filed on Jun 27, 2012 under application number EP18158828A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3351936

CELLESTIS
Application Number
EP18158828A
Filing Date
Jun 27, 2012
Status
Granted And Under Opposition
Dec 6, 2024
Publication Date
Jan 8, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BIOMERIEUX SOCIETE ANONYMEOct 7, 2025BIRD & BIRDADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2001AU00420
DESCRIPTIONUS4016043
DESCRIPTIONUS4018653
DESCRIPTIONUS4424279
DESCRIPTIONWO2005118629
OPPOSITIONEP1723426
OPPOSITIONEP2726883
OPPOSITIONUS2004141985
OPPOSITIONWO0026248
OPPOSITIONWO2009121845
OPPOSITIONWO2013000021
OTHEREP2726883
OTHERWO2009121845
SEARCHWO2009121845
SEARCHWO2011075773

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents